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Summary
Background:  The  hepatitis  B  virus  (HBV)  poses  a  health  risk  to  healthcare  workers
who  are  in  close  proximity  to  infected  individuals.  Medical  students  are  a  particularly
high-risk  group  due  to  the  lack  of  an  obligatory  vaccination  program  and  a  post-
vaccination  screening  program  to  determine  immunity  status,  which  results  in  a
lack  of  awareness  of  and  compliance  with  the  HBV  vaccine.
Methods:  This  cross-sectional  survey  was  conducted  in  King  Khalid  University  Hospi-
tal  (KKUH),  a  tertiary  care  academic  hospital  in  Riyadh,  Saudi  Arabia,  from  November
2013  to  March  2014.  Medical  students  in  their  second  to  ﬁfth  years  (n  =  444;  213  men
and  231  women)  completed  a  self-administered  questionnaire  regarding  awareness
of  HBV  and  compliance  with  the  HBV  vaccination  program  in  KKUH.
Results:  Medium  to  low  knowledge  levels  were  present  in  53.5%  of  the  participants,
and  44.3%  reported  that  they  were  not  compliant  with  the  vaccination  program
provided  by  KKUH.  While  93.9%  received  the  HBV  vaccine  upon  entry  to  medical
school,  only  59.5%  received  all  3  doses,  citing  forgetfulness  and  a  busy  schedule
as  common  reasons  for  the  low  compliance.  There  was  no  association  between  the
knowledge  and  awareness  of  the  participants  and  their  compliance  (p  = 0.988).
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Conclusion:  Medical  students  had  a low  level  of  compliance  with  the  HBV  vaccination
program,  regardless  of  their  knowledge  and  awareness  of  the  disease  and  vaccination.
grams  and  campaigns  be  developed  to  increase  the  overall
.  We  also  suggest  that  a  mandatory  HBV  vaccination  program
to  improve  the  compliance  rate  among  medical  students.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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A  self-administered  questionnaire  was  distributed
to all  participants,  which  included  questions
regarding the  compliance  rate  and  level  of  aware-We  recommend  that  pro
awareness  of  this  disease
should  be  implemented  
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epatitis  B  virus  (HBV)  is  a  virulent  pathogen  from
he family  hepadnaviridae,  which  includes  hepatitis
 surface  antigen  (HBsAg),  HB  core  antigen  (HBcAg),
nd HB-e  antigen  (HBeAg)  [1,2].  HBV  infection  is  a
ell-known  cause  of  acute  and  chronic  hepatitis,
hich can  progress  to  liver  cirrhosis  or  hepato-
ellular carcinomas.  In  the  Middle  East  and  South
sia, 2—5%  of  the  entire  population  is chroni-
ally affected,  and  more  than  240  million  people
ave chronic  liver  disease  globally,  with  an  average
00,000  subsequent  annual  deaths  as  of  July  2013
3].
HBV  infection  poses  a  health  risk  to  healthcare
orkers who  are  in  close  proximity  to  infected  indi-
iduals  and  their  bodily  ﬂuids.  Medical  students
n tertiary-care  academic  hospitals  are  a  particu-
arly high-risk  and  overlooked  group  in  the  current
iterature. Given  the  high  rates  of  HBV-associated
ortality,  it  is  important  to  study  HBV  infection  in
hese students.
The Kingdom  of  Saudi  Arabia  (KSA)  was  an
BV-endemic nation  until  the  HBV  vaccine  was
ntroduced  in  1989,  following  which  there  was  a
igniﬁcant  decrease  in  HBV  sero-prevalence,  from
% before  the  vaccination  program  to  0.3%  in
997 [4].  Despite  this  milestone,  several  Saudi  sub-
opulations,  including  pregnant  women,  students  in
ealth programs,  and  health  care  workers,  remain
t risk  [5,6].  Recent  local  and  regional  studies  also
rovide  evidence  regarding  decreased  awareness  of
BV among  several  groups  in  the  Saudi  community
ncluding military  personnel  [7],  primary  health-
are physicians  [8],  and  medical  students  [9,10];
his evidence  suggests  that  compliance  with  vac-
ination  programs  might  be  signiﬁcantly  related
ith one’s  perceptions  and  misconceptions  about
BV and  other  chronic  infectious  diseases.  A  study
onducted  in  King  Abdulaziz  University  in  Jeddah,
hich has  a  high-risk  group  who  have  contact  with
lood  and  ﬂuids  during  dental  procedures,  reported
n 80.5%  compliance  rate  for  HBV  vaccination;  how-
ver, more  than  half  (57.5%)  of  those  vaccinated
ere not  screened  for  HBV  antibodies  [11].  In  this
n
s
tross-sectional  study,  we  aimed  to  determine  med-
cal students’  knowledge  of  HBV  and  vaccination
s well  as  their  compliance  with  the  vaccination
rogram at  King  Khalid  University  Hospital  (KKUH),
iyadh,  KSA.  In  addition,  we  aimed  to  ascertain
he relationships  between  awareness  and  preven-
ive behaviors  and  compliance  with  vaccine  in  the
edical students.
ethods
ubjects
his  cross-sectional  study  was  conducted  at  the  Col-
ege of  Medicine,  KKUH,  King  Saud  University  (KSU),
iyadh, KSA  between  October  2013  and  March  2014.
andom  stratiﬁed  sampling  was  used  to  acquire  a
ohort of  480  medical  students  (240  men  and  240
omen),  based  on  a  sample  size  calculation  for
roportions  in  a single  population  using  informa-
ion from  a pilot  study  conducted  with  14  medical
tudents in  the  same  college,  during  which  35.7%
f the  participants  complied  with  the  vaccine  pro-
ram, and  64.3%  did  not  (p  =  0.357).  The  calculated
ample size  was  353,  but  a sample  size  of  480  was
sed for  better  representation  of  the  population.
ll second-  to  ﬁfth-year  students  were  eligible;
rst-year students  were  excluded  to  ensure  that  all
ubjects had  the  chance  to  undergo  the  full  vac-
ination  program.  The  institutional  review  board
pproved  the  study  design,  and  each  participant
rovided written  consent.  All  of  the  participant
nformation was  kept  conﬁdential,  and  no  incen-
ives were  provided  for  participation.
ata collection and questionnaireess of  HBV  and  the  vaccination  program  within  two
ections. The  ﬁrst  section  consisted  of  12  questions
o assess  knowledge  regarding  the  disease  itself
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Table  1  Medical  students’  knowledge  and  awareness  of  the  hepatitis  B  virus  (HBV)  and  HBV-related  information.
Knowledge  about  n  (%)  Points
HBV  Virus  427  (96)  1
Infectious  343  (77.1)  1
Acute  and  chronic 223  (50.1) 2
Acute  or  chronic 77  (17.3) 1
Transmission  Perinatal  254  (57.1)  1
Blood-borne  355  (79.8)  1
Sexual  293  (65.8)  1
Bodily  ﬂuids  of  an  infected  person  187  (42.0)  1
Prevention  and
risk
Vaccination  360  (80.9)  1
Hazardous  428  (96.2)  1
Complications Hepatocellular  carcinoma  298  (67.0)  1
Hepatic  cirrhosis  377  (84.7)  1
HBV  vaccine Vaccine  availability  444  (99.8)  1
3  doses  380  (85.4)  1
Intramuscular  370  (83.1)  1
Surface  antigen  recombinant 182  (40.9)  1
Subunit  88  (19.8) 1
When  should  the
vaccine  be
administered?
Before  enrolling  into  medical  college  217  (48.8)
No points  given
1st  year  of  college 145  (32.6)
Before  starting  clinical  rotations 30  (6.7)
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(type  of  pathogen,  course  of  the  disease,  routes  of
transmission,  preventive  measures,  complications)
and the  level  of  awareness  to  the  HBV  vaccination
program (number  of  doses,  type  of  vaccine,  route
of administration),  and  the  score  was  used  to  cat-
egorize  participants  into  low  (<8  points),  medium
(8—13  points),  and  high  (≥14  points)  knowledge
groups; these  cut-offs  were  determined  based  on
the pilot  study  (see  Table  1  for  more  information).
The second  section  of  the  questionnaire  consisted
of 6  questions  regarding  the  compliance  rate  with
the HBV  vaccination  program  at  KKUH,  which
typically consists  of  3  doses  of  vaccine  set  on
intervals starting  from  the  ﬁrst  day  of  enrollment
to the  medical  school  (1st  dose)  then  given  after
1 month  (2nd  dose)  then  ﬁnally  6  months  after  the
ﬁrst dose  (3rd  dose).
Data analysis
Microsoft  Excel  2013  was  used  for  data  entry,  and
SPSS version  16.5  (SPSS  Inc.,  Chicago,  IL,  USA)  was
used for  descriptive  analyses.  Data  are  presented
as frequencies  and  percentages  (%),  and  Chi-square
tests  were  used  to  compare  the  responses.
ResultsOf  the  480  questionnaires,  444  (213  men  and  231
women)  were  returned  (92.5%  response  rate).  The
responses  are  shown  in  Table  1.
k
e
p45  (10.1)
Regarding  knowledge  levels  of the  disease  and
accine,  46.5%  (n  =  206),  50.4%  (n  =  224),  and  3.1%
n =  14)  had  high,  medium,  and  low  levels  of  knowl-
dge, respectively.  More  women  had  high  levels  of
nowledge  of  the  disease  and  vaccine  (56.5%)  than
en (43.5%).  In  addition,  more  third-year  medi-
al students  (n  = 117)  had  high  levels  of  knowledge
n =  73;  35.3%  out  of  total  number  of  participants),
hereas the  lowest  proportion  (n  =  31;  15%  of  total)
as present  in  second-year  students  (n  =  115).  Only
7.1% (n  = 254)  and  65.8%  (n  =  293)  of  the  partic-
pants knew  that  the  virus  can  be  transmitted
erinatally and  through  sexual  intercourse,  respec-
ively. Furthermore,  72.4%  (321)  knew  that  the  HBV
accine is  part  of  the  Extended  Program  of  Immu-
ization (EPI)  for  children.
Regarding  compliance  with  the  vaccination  pro-
ram, 93.9%  (n  =  417)  received  the  HBV  vaccine
pon entry  to  medical  school.  Approximately  half
f the  participants  (59.5%,  n = 248)  received  all
 doses  of  the  vaccine,  15.6%  (n  =  65)  received
 doses,  and  12.7%  (n  =  53)  received  only  1
ose; 12%  (n =  50)  either  did  not  know  or
ere lost  to  follow  up.  Interestingly,  women
eported a  higher  level  of  non-compliance  (24.7%)
han  men  (19.3%),  despite  better  knowledge
nd awareness.  Moreover,  even  though  second-
ear medical  students  had  the  lowest  levels  of
nowledge,  they  reported  slightly  higher  lev-
ls of  compliance  (14.9%  of  the  fully  compliant
articipants;  n =  66)  compared  with  ﬁfth-year
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gFigure  1  Reasons  for  HB
edical  students  (13.5%  of  the  fully  compliant  par-
icipants;  n =  60).  Different  reasons  were  reported
or non-compliance,  with  forgetfulness  being  the
ost commonly  reported  reason  (Fig.  1).
Only 28.5%  (n  =  127)  of  the  participants  reported
hat they  still  had  a  vaccination  certiﬁcate,  28.8%
n = 128)  did  not  have  one,  15.5%  (n  =  69)  had
ot received  a  certiﬁcate,  23.4%  (n  =  104)  were
naware if  they  had  received  one,  and  13.6%
n = 16)  did  not  respond.  Regarding  immunity  sta-
us, 42.8%  (n  =  190)  had  a  blood  test  to  check
or immunity  against  HBV.  Of  these  participants,
1.6% (n  =  174)  knew  the  result  of  their  tests;  95.4%
n = 166)  were  immune,  and  4.59%  (n  =  8)  were
ot immune.  Of  those  who  were  immune,  62.64%
n = 109)  were  compliant  with  the  vaccination  pro-
ram, and  32.75%  (n  =  57)  were  not  compliant;  of
hose who  were  not  immune,  5  were  compliant,  and
nly 3 were  not  compliant.  The  association  between
he participant’s  awareness  and  his/her  compliance
as  not  statistically  signiﬁcant  (p  =  0.988).
iscussion
he  awareness  and  knowledge  of  HBV  and  vaccina-
ion of  medical  students  in  a  Saudi  tertiary  hospital
n the  present  study  were  modest,  at  best.  There
ere  differences  between  the  school  years,  with
he highest  number  of  participants  scoring  high
evels  of  knowledge  in  the  third-year  class.  Fur-
hermore,  there  was  an  almost  equal  distribution
f knowledge  levels  in  the  fourth-  and  ﬁfth-year
edical students,  who  were  undergoing  clinical
lacements, and  these  levels  were  constantly  lower
t
H
C
sogram  non-compliance.
han  those  of  the  third-year  medical  students.  This
epresents  a  paradox  because  students  in  their
ourth  and  ﬁfth  years  have  received  more  instruc-
ion and  gained  more  experience  through  clinical
lacements. Therefore,  further  investigation  is
arranted  to  determine  the  underlying  reasons  for
hese differences.  Nevertheless,  we  observed  the
ollowing  during  the  present  study:  because  third-
ear students  had  ﬁnished  a  community  medicine
ourse prior  to  participating  in  this  study,  they
ad more  recent  knowledge  acquisition  of  the  dis-
ase and  the  vaccine;  the  third  year  of  medicine
s the  introductory  year  for  the  subsequent  clini-
al years,  which  might  explain  a better  awareness
f potential  nosocomial  infections;  and  second-year
tudents are  relatively  new  to  the  ﬁeld  of  medicine
nd might  have  insufﬁcient  information  regarding
he disease  and  vaccine,  which  would  explain  their
onsistently  lower  scores.
Furthermore,  the  results  indicate  that  high  lev-
ls of  knowledge  among  medical  students  are  not
n indicator  of  acceptable  levels  of  compliance
ith the  vaccination.  Similar  studies  conducted
mong Arab  medical  students  showed  lower  HBV
wareness  in  countries  such  as  Syria  [12]  and  sim-
lar levels  of  awareness  in  dental  students  in  Iran
13]. In  developing  countries  such  as  Laos,  the
ow awareness  and  knowledge  of  HBV  among  stu-
ents and  health  professionals  are  the  main  reasons
or lack  of  vaccination  coverage  [14].  However,
ood knowledge  of  HBV  coupled  with  poor  vaccina-
ion compliance  also  increases  the  risk  of  acquiring
BV; a study  conducted  with  medical  students  in
ameroon  showed  a high  rate  of  accidental  expo-
ure with  very  low  HBV  vaccination  uptake  [15].
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Despite  the  availability  of  an  HBV  vaccine,  only  56%
of the  participants  in  the  present  study  completed
the recommended  doses,  and  more  than  half  of
those who  were  less  compliant  either  forgot  to  com-
plete their  dose  or  were  too  busy,  highlighting  the
lack of  priority  in  adhering  to  the  HBV  vaccination
program at  KKUH.
Completion  of  multi-dose  vaccinations  such  as
the HBV  vaccine  is a  constant  challenge  for
the medical  community.  Developed  countries  such
as the  UK  and  Australia  offer  modest  ﬁnancial
incentives to  its  target  population,  which  has  signif-
icantly increased  adherence  with  the  HBV  vaccine
doses, leading  to  full  completion  [16,17].  However,
ﬁnancial  incentives  to  increase  compliance  may
not be  needed  for  medical  students,  because  HBV
vaccination  is  already  part  of  the  universal  safety
precautions among  medical  workers,  which  should
be enough  of  an  incentive.  Medical  students  in  the
KSA have  similar  poor  compliance  as  medical  stu-
dents in  Italy  (47%),  but  with  a  good  seroconversion
rate (93.1%)  [18];  however,  this  was  assessed  pri-
marily by  recall  in  the  present  study.
The concept  of  booster  doses  is  also  important.
Alfaleh and  colleagues  observed  excellent  long-
term protection  with  the  HBV  vaccine  among  1355
Saudi students  at  18  years  post-vaccination  [19],
suggesting that  booster  doses  for  the  adult  popula-
tion,  such  as  the  present  medical  students,  might
not be  necessary.  However,  a  more  recent  study  by
Al Ghamdi  and  colleagues  supports  sex  differences
in long-term  HBV  protection,  with  women  more
likely to  maintain  long-term  efﬁcacy  from  the  HBV
vaccine than  men  [20]. Regardless  of  the  duration
of HBV  vaccine  protection,  medical  students  should
continue  to  be  vigilant  in  their  protection  against
HBV by  refreshing  their  knowledge  and  awareness
of and  increasing  their  compliance  with  the  multi-
dose requirements  for  full  HBV  protection  because
they remain  a  high-risk  population.
There are  several  limitations  in  the  present
study. The  cross-sectional  nature  limits  the  deter-
mination  of  any  causal  relationships.  Further
investigations should  include  detection  of  rele-
vant markers  (HBV  antibodies)  to  provide  better
evidence for  seroconversion  in  this  population.
Rates of  accidental  exposure  and  potential  HBV  risk
should also  be  determined,  which  might  increase
compliance among  medical  students  who  are  not
fully aware  of  their  risk  for  HBV  exposure.  Never-
theless, to  the  best  of  our  knowledge,  the  present
study is  the  ﬁrst  to  investigate  the  knowledge
and awareness  of  HBV  in  medical  students  in  the
capital  Riyadh  and  highlights  the  importance  of
further investigation  of  HBV  vaccine  programs  in
KSA.F.A.  Ghomraoui  et  al.
In  conclusion,  almost  half  of  the  study  partic-
pants had  medium  to  low  knowledge  levels  of
BV, and  almost  half  of  the  participants  were  non-
ompliant  with  the  vaccination  program  provided
y the  KKUH.  Awareness  programs  and  campaigns
hould be  developed  to  increase  the  overall  aware-
ess and  prevention  of  this  disease.  In  addition,
e recommend  the  implementation  of  administra-
ive policies,  which  will  guarantee  that  all  students
re covered  by  the  vaccination  program.  Further
tudies should  be  conducted  to  determine  the  real
ssociation  between  immunity  levels  and  vaccine
ompliance  and  whether  the  current  vaccination
rograms are,  in  fact,  effective.
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